Kedplasma

Kedplasma specializes in the collection and procurement of high-quality plasma, a critical component processed into plasma-based therapies for treating severe and rare diseases. Established in 2004, the company operates within the Healthcare and Medical Testing & Clinical Laboratories industries, focusing on a vital segment of the biopharmaceutical supply chain. KEDPLASMA's mission is to support life-saving treatments by ensuring a consistent and safe supply of plasma. They operate over 70 donation centers nationwide, offering individuals over 18 a compensated and secure donation experience. A dedicated donor app is available for managing donations and rewards, enhancing donor engagement.

The company maintains a substantial operational scale, employing between 500 and 1,000 individuals across its 29 locations. This extensive network facilitates its core function of plasma collection. KEDPLASMA is committed to providing a positive and ethical donation process, encouraging healthy individuals to contribute to the availability of essential medical treatments. Meet Kedplasma's team to learn more about the professionals dedicated to this crucial work.

The primary product is plasma, which is transformed into therapies for complex medical conditions. KEDPLASMA's revenue stands at $26.7M, underscoring its significant role in the healthcare sector. The company's strategic emphasis on plasma collection and processing positions it as a key contributor to medical advancements and patient care, directly impacting the availability of treatments for rare and severe diseases.